The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.
The Impact of Fatigue on Patients with Multiple Sclerosis
Open accessAbstract
Although fatigue is recognized as a symptom of MS, there have been insufficient methods for evaluating this symptom. We administered the Fatigue Impact Scale to 85 MS patients and 20 hypertensive patients. Neurologic impairment, mental health, and general health status were also assessed. MS patients reported significantly higher fatigue impact than hypertensive patients. Most MS patients reported fatigue as either their worst (14%), or one of their worst (55%) symptoms. Disease classification and neurologic impairment had little bearing on Fatigue Impact Scale scores in the MS sample. The best predictive models for mental health and general health status in the MS sample both included the Fatigue Impact Scale as a significant factor. This study demonstrates that: 1) fatigue is a very prevalent and severe problem in MS, 2) fatigue impact cannot be predicted by clinical measures of neurologic impairment, 3) fatigue has a significant effect on the mental health and general health status of MS patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“is often considered to be the worst symptom of disease (Fisk et al., 1994”
From Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis (2016) · cites this paper as Fisk et al., 1994
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Krupp, L. B. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520460115022 · Cited by 6,172
The Revised UCLA Loneliness Scale: concurrent and discriminant validity evidence
Russell, D., Peplau, L. A., & Cutrona, C. E. (1980) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.39.3.472 · Cited by 5,173
The Sickness Impact Profile: Development and Final Revision of a Health Status Measure
Bergner, M., Bobbitt, R. A., Carter, W. B., & Gilson, B. S. (1981) · Medical Care · doi:10.1097/00005650-198108000-00001 · Cited by 4,619
The structure of psychological distress and well-being in general populations.
Veit, C. T., & Ware, J. E. (1983) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.51.5.730 · Cited by 2,094
Krupp, L., Alvarez, L., LaRocca, N. G., & Lc, S. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520280085020 · Cited by 999
Symptomatic fatigue in multiple sclerosis.
Freal, J. E., Kraft, G. H., & Coryell, J. K. (1984) · PubMed · Cited by 526
Affective Disorders in Multiple Sclerosis Review and Recommendations for Clinical Research
Minden, S. L., & Schiffer, R. B. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530010124031 · Cited by 415
Measuring quality of life in clinical trials: a taxonomy and review.
Guyatt, G. H., van Zanten, S. J. V., Feeny, D. H., & Patrick, D. L. (1989) · Europe PMC (PubMed Central) · Cited by 408
Prigatano, G. P. (1984) · Archives of Internal Medicine · doi:10.1001/archinte.1984.00350200121018 · Cited by 300
Research works printed but not linked: 4
- 1987, American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders-Revised
- Ritvo, A model of mental health in patients with multiple sclerosis, Can Psychol, 33, 391
- McNair, 1971, EDITS Manual for the Profile of Mood States
- 10.1037/0022-006x.51.5.730 · DOI
Cited by
Sorted by citations
Items 601–700 of 1,001
Smith, C. E., & Hale, L. A. (2007) · Physical Therapy Reviews · doi:10.1179/108331907x223056 · Cited by 14
Spitzer, E., & Pakenham, K. I. (2016) · Clinical Psychologist · doi:10.1111/cp.12108 · Cited by 15
Fatigue in Japanese people with multiple sclerosis
Moriya, R., & Kutsumi, M. (2010) · Nursing and Health Sciences · doi:10.1111/j.1442-2018.2010.00554.x · Cited by 14
“These include the Fatigue Severity Scale (Krupp et al., 1988), the 40-item Fatigue Impact Scale (Fisk et al., 1994), and the Fatigue Descriptive Scale (Iriarts et al., 1999).”
MethodAssessment, pathophysiology and treatment of fatigue in multiple sclerosis
Comı, G., & Leocani, L. (2002) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2.6.867 · Cited by 14
Neurovegetative Symptoms in Patients with Multiple Sclerosis: Fatigue, not Depression
Rabinowitz, A. R., Fisher, A. J., & Arnett, P. A. (2010) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617710001141 · Cited by 14
“The Fatigue Impact Scale (FIS; Fisk et al., 1994)—The FIS is a 40-item self-report measure designed to assess the effects of fatigue on quality of life in cognitive, physical, and psychosocial domains.”
BackgroundMethodInfluentialOccupational Therapy for the Management of Fatigue in Multiple Sclerosis
Bowcher, H., & May, M. (1998) · British Journal of Occupational Therapy · doi:10.1177/030802269806101101 · Cited by 14
Benešová, Y., & Tvaroh, A. (2016) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285616671882 · Cited by 15
Cognitive fatigue: an impaired cortical inhibitory replenishment
Touzet, C. F. (2017) · Brain Injury · doi:10.1080/02699052.2017.1344300 · Cited by 14
“Fatigue is one of the most common symptoms reported in 70-90% of patients with Multiple Sclerosis (MS) [10-11], and 40% of MS patients rate it to be their most troubling symptom.”
BackgroundPsychometric Properties of Three Fatigue Rating Scales in Individuals With Late Effects of Polio
Lexell, J. E., Jonasson, S. B., & Brogårdh, C. B. (2018) · Annals of Rehabilitation Medicine · doi:10.5535/arm.2018.42.5.702 · Cited by 14
“The three most commonly used scales to assess fatigue in persons with LEoP include the Fatigue Severity Scale (FSS) [11], the Fatigue Impact Scale (FIS) [12], and the Multidimensional Fatigue Inventory (MFI-20) [13].”
BackgroundMethodKratz, A. L., Alschuler, K. N., Ehde, D. M., von Geldern, G., Little, R. J. A., Kulkarni, S., Pickup, K., & Braley, T. J. (2019) · Contemporary Clinical Trials · doi:10.1016/j.cct.2019.105821 · Cited by 14
Seze, J. D., Devy, R., Planque, E., Delabrousse-Mayoux, J. P., Vandhuick, O., Kabir, M., & Benblidia, A. G. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102659 · Cited by 14
“%) symptoms (Fisk et al., 1994).”
Primary and Nonprimary Fatigue in Multiple Sclerosis
Forwell, S. J., Brunham, S., Tremlett, H. L., Morrison, W., & Oger, J. J.-F. (2008) · International Journal of MS Care · doi:10.7224/1537-2073-10.1.14 · Cited by 14
“John’s wort (Hypericum perforatum) (1) Analgesics Butalbital-codeine compound (2), codeine (1) Antimigraine (5-HT1 agonists) Rizatriptan (1), sumatriptan (1) Benzodiazepines and other hypnotics Oxazepam (1), nitrazepam (1), triazolam (1), zopiclone (1) Skeletal muscle relaxants Baclofen (1), tizanidine (2) Miscellaneo…”
BackgroundKasatkin, D. S., & Спирин, Н. А. (2007) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-007-0004-9 · Cited by 14
“Fatigue in MS is independent of its other symptoms [18, 23] and may be severe even during the phase of quiescence of the autoimNeuroscience and Behavioral Physiology, Vol.”
BackgroundYoung Adults With Multiple Sclerosis: Management in the Home
Holland, N. J., & Northrop, D. E. (2006) · Home Health Care Management & Practice · doi:10.1177/1084822305281952 · Cited by 14
Cholinergic Treatment of Traumatic Brain Injury
Tenovuo, O. S. (2006) · Current Drug Therapy · doi:10.2174/157488506776930932 · Cited by 14
Smyth, P. S., Watson, K. E., & Tsuyuki, R. T. (2021) · Trials · doi:10.1186/s13063-021-05726-3 · Cited by 13
“Secondary outcomes will include difference in change in HADS at 6 months; Modified Fatigue Impact Scale scores (MSIF) at 3 and 6 months; EQ-5D scores at 3 and 6 months; caregiver health-related quality of life in MS measures (CAREQOL-MS) at 3 and 6 months; number of visits and phone calls to healthcare professionals r…”
MethodInfluentialSmyth, P. S., Watson, K. E., Hamarneh, Y. N. A., & Tsuyuki, R. T. (2022) · BMC Neurology · doi:10.1186/s12883-022-02809-9 · Cited by 13
“Secondary outcomes included difference in change in a) HADS-D and HADS-A scores at 6 months, b) EQ5D at 3 and 6 months [38], and c) Modified Fatigue Impact Scale (MFIS) score at 3 and 6 months [43, 44], and patient satisfaction with care as measured by the validated Consultation Satisfaction Questionnaire (CSQ) [45–48…”
MethodAhvenjärvi, H., Niiranen, M., Simula, S., Hämäläinen, P. I., Surcel, H., Remes, A. M., Ryytty, M., & Krüger, J. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104861 · Cited by 12
Gould, J. R., Reineberg, A. E., Cleland, B. T., Knoblauch, K. E., Clinton, G. K., Banich, M. T., Corboy, J. R., & Enoka, R. M. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01404 · Cited by 15
“…(Lublin and Reingold, 1996; Confavreux and Vukusic, 2006), one of the most common symptoms of the disease is a heightened level of fatigue (Fisk et al., 1994; Alvarenga-Filbo et al., 2015; Loy et al., 2017; Penner and Paul, 2017), the underlying mechanisms of which are poorly understood.”
BackgroundPlow, M. A., Packer, T. L., Mathiowetz, V. G., Preissner, K., Ghahari, S., Sattar, A., Béthoux, F., & Finlayson, M. L. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035470 · Cited by 13
Eldemir, K., Guclu‐Gunduz, A., Özkul, Ç., Eldemir, S., Söke, F., & İrkeç, C. (2021) · Fatigue Biomedicine Health & Behavior · doi:10.1080/21641846.2021.1923995 · Cited by 13
Patient-reported outcomes associated with transition to secondary progressive multiple sclerosis
Healy, B. C., Zurawski, J. D., Chitnis, T., Weiner, H. L., & Glanz, B. I. (2021) · Quality of Life Research · doi:10.1007/s11136-021-03034-6 · Cited by 13
“Fatigue was assessed using the Modified Fatigue Impact Scale (MFIS), which is a 21-item measure of physical, mental and psychosocial fatigue [19].”
MethodBois, A., Tervil, B., Moreau, A., Vienne-Jumeau, A., Ricard, D., & Oudre, L. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268475 · Cited by 13
“In the case of MS, several clinical scales exist such as the Expanded Disability Status Scale (EDSS) [3], the Multiple Sclerosis Walking Scale-12 [4], and the Fatigue Impact Scale [5, 6].”
MethodBerardi, A., Graziosi, G., Ferrazzano, G., Conti, L. C., Grasso, M. G., Tramontano, M., Conte, A., & Galeoto, G. (2022) · Healthcare · doi:10.3390/healthcare10060985 · Cited by 14
Multiple Sclerosis and Fatigue
Cook, K. F., Bamer, A. M., Roddey, T., Kraft, G. H., Kim, J., & Amtmann, D. (2013) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2013.06.006 · Cited by 13
de Carvalho, S. R. D. S., Filho, H. A., Alvarenga, R. M. P., Chacur, F. H., & Dias, R. M. (2012) · Respirology · doi:10.1111/j.1440-1843.2012.02191.x · Cited by 13
Depression as a predictor of occupational transition in a multiple sclerosis cohort.
Patten, S. B., Williams, J. V. A., Lavorato, D. H., Koch, M. W., & Metz, L. M. (2013) · Europe PMC (PubMed Central) · Cited by 13
Impaired sleep-associated modulation of post-exercise corticomotor depression in multiple sclerosis
Bridoux, A., Créange, A., Sangaré, A., Ayache, S. S., Hosseini, H., Drouot, X., & Lefaucheur, J. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.05.006 · Cited by 13
“Most studies on fatigue in MS used subjective self-report questionnaires [2,10].”
BackgroundBaumstarck, K., Rebeschini, E., Dalivoust, G., Durand-Bruguerolle, D., Gazazian, G., & Martin, F. (2008) · La Presse Médicale · doi:10.1016/j.lpm.2008.06.018 · Cited by 13
Preliminary Results: Effect of Whole-Body Cooling in Patients with Myasthenia Gravis
Mermier, C. M., Schneider, S. M., Gurney, A. B., Weingart, H., & Wilmerding, M. V. (2005) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000180887.33650.0f · Cited by 13
Guillamò, E., Cobo‐Calvo, Á., Oviedo, G. R., Travier, N., Álamo, J., Niño-Méndez, O. A., Martı́nez-Yélamos, A., Martínez‐Yélamos, S., & Javierre, C. F. (2018) · Europe PMC (PubMed Central) · Cited by 13
Fatigue management by speech-language pathologists for adults with traumatic brain injury
Hicks, E., Larkins, B., & Purdy, S. C. (2010) · International Journal of Speech-Language Pathology · doi:10.3109/17549507.2011.485329 · Cited by 13
Transdermal histamine in multiple sclerosis, part two: a proposed theoretical basis for its use.
Gillson, G., Wright, J. V., DeLack, E., & Ballasiotes, G. (2000) · PubMed · Cited by 13
Validation of two new scales for the assessment of fatigue in Multiple Sclerosis: F-2-MS and FACIT-F
Delgado‐Álvarez, A., Matías‐Guiu, J. A., Delgado‐Alonso, C., Cuevas, C., Palacios‐Sarmiento, M., Vidorreta-Ballesteros, L., Montero‐Escribano, P., & Matías‐Guiu, J. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103826 · Cited by 13
Biasi, M. M., Manni, A., Pepe, I., Abbatantuono, C., Gasparre, D., Iaffaldano, P., Simone, M., Caro, M. F. D., Trojano, M., Taurisano, P., et al. (2023) · BMC Psychology · doi:10.1186/s40359-023-01235-x · Cited by 12
“In fact, some studies show that it is the combination of fatigue and mood that accounts for a substantial portion of the total variance in cognitive deficits [38, 40].”
BackgroundJackson, K. J., & Bigelow, K. E. (2013) · PM&R · doi:10.1016/j.pmrj.2013.06.001 · Cited by 12
“In addition, 65%-97% of people with MS experience significant fatigue, with 15%-40% who consider it their most disabling symptom [4-7].”
BackgroundBose, G., & Freedman, M. S. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117324 · Cited by 12
Cognitive and Central Vestibular Functions Correlate in People With Multiple Sclerosis
Cochrane, G. D., Christy, J. B., Sandroff, B. M., & Motl, R. W. (2021) · Neurorehabilitation and neural repair · doi:10.1177/15459683211046268 · Cited by 12
Ayache, S. S., Bardel, B., Lefaucheur, J., & Chalah, M. A. (2021) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2003079 · Cited by 12
Sleepiness in neurological disorders
Dubessy, A., & Arnulf, I. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2023.07.005 · Cited by 12
Déficit cognitif et mesure de la qualité de vie dans la sclérose en plaques
Gerbaud, L., Deffond, D., Mulliez, A., Benausse, F., Vernay, D., & Clavelou, P. (2006) · Revue Neurologique · doi:10.1016/s0035-3787(06)75107-4 · Cited by 12
Moreau, T., Bungener, C., Heinzlef, O., Suchet, L., Borgel, F., Bourdeix, I., Meite, M., Rérat, K., Chouette, I., & on behalf of the GRACE Study Group (2016) · European Neurology · doi:10.1159/000451077 · Cited by 12
Karami, F., Afrasiabifar, A., & Doulatabad, S. N. (2018) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.68913 · Cited by 12
Weiland, T. J., Nag, N., Livera, A. M. D., Jelinek, G. A., Neate, S. L., Bevens, W., & Simpson, S. (2021) · European Journal of Neurology · doi:10.1111/ene.14956 · Cited by 12
Validity and reliability of the fatigue impact scale in stroke
Batur, E. B., Taşkıran, Ö. Ö., Yüksel, S., Cengiz, M., & Karataş, G. K. (2021) · Topics in Stroke Rehabilitation · doi:10.1080/10749357.2021.1978629 · Cited by 12
“to evaluate the impact of fatigue on the physical, cognitive, and social functions of multiple sclerosis (MS) patients.(26) However, it has also been used to evaluate fatigue in people with other conditions such as brain injury, Parkinson’s disease, stroke, primary biliary cirrhosis, chronic hepatitis, and chronic obs…”
BackgroundThe Respiratory Muscle Capabilities of Jordanian Patients With Multiple Sclerosis
Natour, Y. S., Marie, B., & Aljunidy, L. (2012) · Journal of Voice · doi:10.1016/j.jvoice.2012.06.007 · Cited by 12
Drug therapy in multiple sclerosis: a study of Nova Scotia senior citizens
SKETRIS, I. S. (1996) · Clinical Therapeutics · doi:10.1016/s0149-2918(96)80012-9 · Cited by 12
Meca-Lallana, J. E., Hernandez, L., Caminero, A. B., Girón, J., Cano-Orgaz, A. T., Carcelén‐Gadea, M., Muñoz, D., Durán-Ferreras, E., Martín-Hernández, J., la Rosa, R. S.-D., et al. (2016) · European Neurology · doi:10.1159/000447630 · Cited by 12
Chronic fatigue—chronically confusing but growing information
Shapiro, C. M. (2004) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(04)00002-9 · Cited by 12
Evaluación clínica de la esclerosis múltiple: cuantificación mediante la utilización de escalas
Ayuso, G. I., & Peña, J. L. R. (2003) · Revista de Neurología · doi:10.33588/rn.3602.2002350 · Cited by 12
“– Fatigue Impact Scale [25].”
Kumar, D. P., Zanotto, T., Cozart, J. S., Bruce, A. S., Befort, C. A., Siengsukon, C. F., Shook, R. P., LYNCH, S. G., Mahmoud, R., Simon, S. D., et al. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.105154 · Cited by 11
A digital intervention for cognitive deficits following COVID-19: a randomized clinical trial
Victoria, L. W., Oberlin, L. E., Ilieva, I. P., Jaywant, A., Kanellopoulos, D., Mercaldi, C. J., Stamatis, C. A., Farlow, D., Kollins, S. H., Tisor, O., et al. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01995-z · Cited by 13
Abou, L., Fritz, N. E., & Kratz, A. L. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104910 · Cited by 11
Jongen, P. J., Heerings, M. A. P., Lemmens, W. A. J. G., Donders, R. A. R. T., van der Zande, A., van Noort, E., & Kool, A. (2015) · BMC Neurology · doi:10.1186/s12883-015-0379-0 · Cited by 11
“A primary determinant of impaired HRQoL in MS is fatigue [11], occurring in over 80 % of patients [12].”
Reconsidérer l’apparition du handicap dès le début de la SEP : la fatigue
Debouverie, M., Pittion‐Vouyovitch, S., & Guillemin, F. (2009) · Revue Neurologique · doi:10.1016/s0035-3787(09)72125-3 · Cited by 11
Fatigue in Neurologic Disorders
Bhat, S., & Chokroverty, S. (2013) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2013.02.006 · Cited by 11
Alghwiri, A. A., Almhdawi, K. A., & Marchetti, G. F. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102596 · Cited by 11
Fakolade, A. O., Walters, A. J., Cameron, J., Latimer‐Cheung, A. E., & Pilutti, L. A. (2019) · Patient Education and Counseling · doi:10.1016/j.pec.2019.10.022 · Cited by 11
Picturing the Multiple Sclerosis Patient Journey: A Symptomatic Overview
Correia, I., Bernardes, C., Cunha, C., Nunes, C. C., Macário, C., Sousa, L., & Batista, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195687 · Cited by 13
“Imbal-ance/discoordination and fatigue have multiple mechanisms, and fatigue may occur regardless of relapses [1,25–28].”
BackgroundLight therapy for multiple sclerosis-associated fatigue
Mateen, F. J., Manalo, N. C., Grundy, S. J., Houghton, M. A., Hotan, G. C., Erickson, H., & Videnović, A. (2017) · Medicine · doi:10.1097/md.0000000000008037 · Cited by 10
Outcome measures assisting treatment optimization in multiple sclerosis
Pardo, G., Coates, S., & Okuda, D. T. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10674-8 · Cited by 14
Brotherton, E. J., Sabapathy, S., McKeown, D. J., & Kavanagh, J. J. (2022) · Journal of Neurophysiology · doi:10.1152/jn.00514.2021 · Cited by 10
Chua, A. S., Glanz, B. I., GUARINO, A. J., Cook, S. L., Greeke, E. E., Little, G. E., Chitnis, T., & Healy, B. C. (2015) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2015.09.004 · Cited by 10
Sleepiness in multiple sclerosis: A pilot study
Beran, R. G., Ainley, L., & Holland, G. (2008) · Sleep and Biological Rhythms · doi:10.1111/j.1479-8425.2008.00361.x · Cited by 10
Andreeva, M. T., & Караваева, Т. А. (2020) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2019-4-2-19-28 · Cited by 11
de Gier, M., Beckerman, H., van Vliet, K., Knoop, H., & de Groot, V. (2020) · Trials · doi:10.1186/s13063-019-3825-2 · Cited by 10
A Rapid Tapping Task on Commodity Smartphones to Assess Motor Fatigability
Barrios, L., Oldrati, P., Lindlbauer, D., Hilty, M., Hayward-Koennecke, H. K., Holz, C., & Lutterotti, A. (2020) · CHI Conference on Human Factors in Computing Systems · doi:10.1145/3313831.3376588 · Cited by 11
Venneri, A., Manca, R., Mitolo, M., Wilkinson, I., Paling, D., & Sharrack, B. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.300450 · Cited by 10
“…Trail Making Test (Armitage, 1946); Stroop test (Wakefield et al., 2014); Digit Symbol Coding Test (Wechsler, 2008); Modified Fatigue Impact Scale (Fisk et al., 1994); Patient Health Questionnaire (Spitzer et al., 1999); Generalized Anxiety Disorder scale (Spitzer et al., 2006); and Multiple…”
Healy, B. C., Glanz, B. I., Swallow, E., Signorovitch, J., Hagan, K. A., Silva, D. A. S., Pelletier, C. L., Chitnis, T., & Weiner, H. L. (2021) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/2055217321999070 · Cited by 10
“The measure of fatigue was the modified fatigue impact scale (MFIS), which is a commonly used measure in MS that includes 21 questions to measure the physical, mental, and psychological components of fatigue.(9) The brief cognitive screening test was the symbol digit modalities test (SDMT), which is a 90second speed o…”
MethodMultimodal emotion perception in young and elderly patients with multiple sclerosis
Montembeault, M., Brando, E., Charest, K., Tremblay, A., Roger, É., Duquette, P., & Rouleau, I. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103478 · Cited by 10
Therapie der Tagesmudigkeit bei Patienten mit multipler Sklerose
Zifko, U. (2003) · Wiener Medizinische Wochenschrift · doi:10.1046/j.1563-258x.2003.02014.x · Cited by 10
Grover, G., Ploughman, M., Philpott, D. T. G., Kelly, L. P., Devasahayam, A. J., Wadden, K. P., Power, K. E., & Button, D. C. (2017) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/2055217317747625 · Cited by 10
“Experimental design During the first session, demographic and MS-related data were collected (age, years since diagnosis, Fatigue Impact Scale (FIS)).(17) PwMS self-reported their degree of heat sensitivity using a”
MethodCaregiver burden in multiple sclerosis
Arnett, P. A. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.115659 · Cited by 10
Román, C. A. F., DeLuca, J., Yao, B., Genova, H. M., & Wylie, G. R. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.828566 · Cited by 12
“Fatigue, including cognitive fatigue, is one of the most common and debilitating symptoms reported by persons with MS (pwMS; Freal et al., 1984; Fisk et al., 1994), impacting employment, quality of life, psychological state, and daily functioning (Nagaraj et al., 2013; Coyne et al., 2015; Tabrizi…”
BackgroundBruce, J. M., Cozart, J. S., Shook, R. P., Ruppen, S., Siengsukon, C. F., Simon, S. D., Befort, C. A., LYNCH, S. G., Mahmoud, R., Drees, B. M., et al. (2021) · Contemporary Clinical Trials · doi:10.1016/j.cct.2021.106495 · Cited by 9
Bellew, D., Davenport, L., Monaghan, R., Cogley, C., Gaughan, M., Yap, S. M., Tubridy, N. J., Bramham, J., McGuigan, C., & O’Keeffe, F. M. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104161 · Cited by 10
Fatigue bei Multipler Sklerose
Flachenecker, P. (2015) · Nervenheilkunde · doi:10.1055/s-0038-1627622 · Cited by 9
Chiu, H.-Y., Li, W., Lin, J.-H., Su, Y.-K., Lin, E.-Y., & Tsai, P.-S. (2018) · Brain Injury · doi:10.1080/02699052.2018.1432893 · Cited by 9
“A review (9) reported that various self-report fatigue measurements, such as the Fatigue Severity Scale (10), the Visual Analog Scale for fatigue (11), the Fatigue Impact Scale (12,13), and the Barrow Neurological Institute Fatigue Scale (14), have been used to assess the fatigue in the TBI population.”
BackgroundMayo, C. D., Harrison, L., Attwell-Pope, K., Stuart-Hill, L. A., & Gawryluk, J. R. (2021) · Pilot and Feasibility Studies · doi:10.1186/s40814-021-00806-2 · Cited by 9
“Participants also completed pre- and post-intervention self-report measures to assess perceived cognitive impairment (attention/concentration, retrospective memory, prospective memory, and planning/organization; Perceived Deficit Questionnaire; PDQ) [24] fatigue (Modified Fatigue Impact Scale; MFIS) [24, 25], and mood…”
MethodNatalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic
Magro, G., Barone, S., Tosto, F., Martino, A., lo, D. S., Manzo, L., Pascarella, A., Bruno, P., Pasquale, M., Gambardella, A., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11408-0 · Cited by 10
Delgado‐Álvarez, A., Díez‐Cirarda, M., Delgado‐Alonso, C., Hernández‐Lorenzo, L., Cuevas, C., Valles‐Salgado, M., Montero‐Escribano, P., Gil‐Moreno, M. J., Matías‐Guiu, J., García-Ramos, R., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220907 · Cited by 10
“…people with AD; Hoehn and Yahr scale [52] for PD-MCI; and Expanded Disability Status Scale [53], Fatigue Severity Scale [54], Modified Fatigue Impact Scale [55], and Beck’s Depression Inventory [56] for MS. HC group was evaluated with MMSE, and also with CDR and FAQ to ensure the inclusion criteria.”
Patients experience of cognitive fatigue post-stroke: an exploratory study
Askari, S., Harvey, K., & Sam-Odutola, M. (2023) · Disability and Rehabilitation · doi:10.1080/09638288.2023.2280065 · Cited by 9
“The screening involved completing a 9-item cognitive fatigue subscale from the Modified Fatigue Impact Scale [15], the Patient Health Questionnaire 9 [17], and the Short Blessed Test for cognitive abilities [18].”
Johnson, S. K., Terrell, D. F., Sargent, C., & Kaufman, M. (2007) · Stress and Health · doi:10.1002/smi.1138 · Cited by 9
Mäurer, M., Schuh, K., Seibert, S. M., Baier, M. L., Hentschke, C., Streber, R., Tallner, A., & Pfeifer, K. (2018) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/2055217318756688 · Cited by 9
[Current possibilities of assessment of quality of life in multiple sclerosis].
Opara, J. A., Jaracz, K., & Brola, W. (2006) · PubMed · Cited by 9
Quality of life following prolonged critical illness: A mixed methods study
Ramsay, P. (2010) · ERA · Cited by 9
Fatigability-related oscillatory brain activity changes in people with MS
Linnhoff, S., Haghikia, A., & Zaehle, T. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104457 · Cited by 8
Matías‐Guiu, J. A., González-Rosa, J. J., Hernández, M. Á., Martínez‐Ginés, M. L., Portolés, A., Pérez-Macías, N., Benito‐León, J., Padrón, I., Prieto, J., & Matías‐Guiu, J. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-078661 · Cited by 8
Giunti, G., Yrttiaho, T., Guardado, S., Sachinopoulou, A., Mylonopoulou, V., Fält, J., Paloniemi, B., Ryytty, M., Krüger, J., & Isomursu, M. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106379 · Cited by 12
“Fatigue is the most prevalent and debilitating symptom in Multiple Sclerosis (MS), impacting up to 80 % of patients (Krupp, 2006; S Pittion-Vouyovitch et al., 2006; V Janardhan and Bakshi, 2002; Fisk et al., 1994; Zwibel, 2009; Hadjimichael et al., 2008).”
Plow, M. A., Gunzler, D. D., & Chang, J. H. (2022) · Quality of Life Research · doi:10.1007/s11136-022-03204-0 · Cited by 8
Cognitive Reserve Moderates the Effects of Fatigue and Depressive Symptoms in Multiple Sclerosis
Bradson, M. L., Cadden, M. H., Riegler, K. E., Thomas, G. A., Randolph, J. J., & Arnett, P. A. (2023) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acad041 · Cited by 9
Crocker, S. H. (2009) · Advances in Nursing Science · doi:10.1097/ans.0b013e3181bd693d · Cited by 8
Fatigue evaluation in fingolimod treated patients: An observational study
Masingue, M., Debs, R., Maillart, É., Delvaux, V., Lubetzki, C., Vidal, J., & Papeix, C. (2017) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2017.03.006 · Cited by 8
Hugos, C. L., Cameron, M. H., Chen, Z., Chen, Y., & BOURDETTE, D. N. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518775920 · Cited by 8
Osteopathic Manipulative Therapy and Multiple Sclerosis: A Proof-of-Concept Study
Cordano, C., Armezzani, A., Veroni, J., Pardini, M., Sassos, D., Infante, M. T., Tacchino, A., Lapucci, C., Cellerino, M., Calabrò, V., et al. (2018) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2018.121 · Cited by 8
Cryotherapy and self-reported fatigue in individuals with multiple sclerosis: A systematic review
Campbell, A., Killen, B. S., Cialone, S. J., Scruggs, M., & Lauderdale, M. (2019) · Physical Therapy Reviews · doi:10.1080/10833196.2019.1674546 · Cited by 8
Agyemang, C., Berard, J. A., & Walker, L. A. S. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103130 · Cited by 8
Ziccardi, S., Pizzini, F. B., Guandalini, M., Tamanti, A., Cristofori, C., & Calabrese, M. (2022) · Bioengineering · doi:10.3390/bioengineering10010041 · Cited by 8
Wilken, J. A., Traboulsee, A. L., Nelson, F. M., Ionete, C., Kolind, S., Fratto, T., Kane, R., Gandhi, R., Rawlings, A. M., Roesch, N., et al. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104677 · Cited by 8
Fahreignung bei Multipler Sklerose
Küst, J., & Dettmers, C. (2014) · Der Nervenarzt · doi:10.1007/s00115-014-4009-7 · Cited by 8
Metadata
- Authors
- Fisk, J. D., Pontefract, A., Ritvo, P. G., Archibald, C. J., & Murray, T. J.
- Affiliations
- Dalhousie University (CA)
- Corresponding author
- Fisk, John D.
- ORCID
- Fisk, John D.
- Venue
- Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Publisher
- Cambridge University Press (CUP)
- Published
- 1994-02
- Volume
- 21
- Issue
- 1
- Pages
- 9-14
- ISSN
- 0317-1671 (ISSN-L)
- 2057-0155
- OpenAlex
- W155259919
- Cited by
- 1,025
- References
- 26
- Citations by year
- 2026: 24 · 2025: 26 · 2024: 34 · 2023: 52 · 2022: 49 · 2021: 63 · 2020: 45 · 2019: 31 · 2018: 46 · 2017: 44 · 2016: 38 · 2015: 56 · 2014: 31 · 2013: 44 · 2012: 38
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Dalhousie University
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Keywords
- multiple sclerosis, fatigue, Fatigue Impact Scale, fatigue effects, mental health, health status, neurological deficit, hypertension, symptom burden, disease classification
- MeSH terms
- Adult, Affect, Aged, Fatigue, Female, Humans, Hypertension, Male, Mental Health, Middle Aged, Multiple Sclerosis, Psychiatric Status Rating Scales, Surveys and Questionnaires
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review